Actavis doubles revenue Skip to content

Actavis doubles revenue

Iceland based pharmaceutical company Actavis Group announced on Wednesday that it had doubled its year-on-year revenue, which was EUR 1,379 million (USD 1.8 billion) last year.

According to Morgunbladid, Actavis Group’s overall profit in 2006 was EUR 103 million (USD 136 million). Actavis CEO Róbert Wessman is reportedly very pleased with the results and said ambitious goals had been achieved.

Actavis invested in four new companies in 2006, focusing primarily on eastern Europe and the US. Last year the sale of medicine increased in those two markets by 12 to 18 percent.

Sign up for our weekly newsletter

Get news from Iceland, photos, and in-depth stories delivered to your inbox every week!

* indicates required

Subscribe to Iceland Review

In-depth stories and high-quality photography showcasing life in Iceland!

Share article